SHIFT Newsroom · GLOBAL
GLP-1 use around pregnancy: a published letter
The cited item is a letter in Diabetes, Obesity and Metabolism about patterns of GLP-1-based therapy use before and after pregnancy.
The cited item is a letter in Diabetes, Obesity and Metabolism about patterns of GLP-1-based therapy use before and after pregnancy. The bibliographic record reviewed for this audit provides no abstract. It therefore cannot support claims here about pregnancy safety, benefit or a change in prescribing. Reporting use around pregnancy is different from demonstrating that treatment during pregnancy is safe.
SHIFT’s take
Read the study design and limits alongside the finding. This article does not determine individual treatment suitability.